Talk:Taribavirin
From Wikipedia, the free encyclopedia
 |
Taribavirin is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| Start | This article has been rated as Start-Class on the quality scale. |
|
|
|
 |
This article is within the scope of the Viruses WikiProject, a collaborative effort to improve and organize articles about biological viruses on Wikipedia. Please work to improve this article, or visit our project page to find other ways of helping. Thanks! | ||
| Start | This article has been rated as Start-Class on the assessment scale. | ||
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need. |
|||
I've just started the stub on viramidine. It still has some errors in it. Sbharris 06:48, 6 December 2005 (UTC)
Okay, the errors are mostly out. Comments from readers welcome. Sbharris 03:50, 13 January 2006 (UTC)
[edit] Ribapharm not a predecessor of Valeant
According this company press release, Ribapharm was a subsidiary of ICN Pharamceuticals, not a predecessor
http://www.valeant.com/mediaCenter/newsArticle/newsArticle.jspf?objectId=319
